Arcutis Biotherapeutics to Discuss ZORYVE® (Roflumilast Cream 0.15%) FDA Approval in Upcoming KOL Event
Jul 23, 2024
Arcutis Equities
Arcutis Biotherapeutics Announces New Inducement Grants in Accordance with Nasdaq Rules
Dec 3, 2023
Arcutis Biotherapeutics Announces Recent Inducement Grants According to Nasdaq Rules
Dec 3, 2023